{"product_id":"24-postgraduate-course-bonus-sessions-2021","title":"24 Postgraduate Course Bonus Sessions 2021","description":"\u003cdiv class=\"titleBar\"\u003e\n\u003cdiv id=\"MainContent_MainContent_ucLearningActivityCatalog_Details___learningActivityCatalog_SideBySideDetails_pnlLearningActivitySubtitle\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv class=\"panel entry-content active\" id=\"tab-description\"\u003e\n\u003cdiv class=\"woocommerce-tabs wc-tabs-wrapper container tabbed-content\"\u003e\n\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"section__description\"\u003e\n\u003cdiv\u003eBonus Sessions\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eSeparate Purchase Required – Must be registered for the Postgraduate Course to purchase access to these sessions.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e(Formerly Learning Luncheons)\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003e24 Postgraduate Course Bonus Sessions 2021\u003c\/div\u003e\n\u003cdiv\u003ePeri-Procedural Anticoagulation: WWND (What Would Neena Do)?\u003c\/div\u003e\n\u003cul\u003e\n\u003cli\u003eNeena S. Abraham, MD, MSc (Epid), FACG\u003c\/li\u003e\n\u003cli\u003eDescribe an evidence-based approach for management of peri-procedural anticoagulation – from routine outpatient procedures to therapeutic interventions for GI bleeding. Perianal Crohn’s Disease – Evolutions in Management\u003c\/li\u003e\n\u003cli\u003eMiguel D. Regueiro, MD, FACG\u003c\/li\u003e\n\u003cli\u003eReview the latest management of perianal Crohn’s disease, including novel therapeutics, combined medical and surgical approaches and optimization of therapies. CAM and Psychological Therapies for Functional and Inflammatory Bowel Disease\u003c\/li\u003e\n\u003cli\u003eJill K. Deutsch, MD, and Laurie A. Keefer, PhD\u003c\/li\u003e\n\u003cli\u003eApply current evidence-based strategies for functional bowel disease including both pharmacologic and mind-based therapies such as cognitive behavioral therapies and hypnotherapy. Hereditary Pancreatic Cancers – Who Should We Screen and How?\u003c\/li\u003e\n\u003cli\u003eYasmin G. Hernandez-Barco, MD\u003c\/li\u003e\n\u003cli\u003eReview the role of genetic screening and screening with imaging for pancreatic cancer with a review of the relevant genes and imaging modalities to consider. Management of Disorders of the J-Pouch: A Practical Guide\u003c\/li\u003e\n\u003cli\u003eLaura E. Raffals, MD, MS, FACG\u003c\/li\u003e\n\u003cli\u003eReview approaches to the endoscopic assessment of the J-pouch, common disorders of the pouch, and medical management. Nutrition 101 for the Gastroenterologist: A Case-Based Approach\u003c\/li\u003e\n\u003cli\u003eJohn K. DiBaise, MD, FACG\u003c\/li\u003e\n\u003cli\u003eImprove recognition of nutrient deficiencies, review modalities of nutrition support, recognize the warning signs of eating disorders, and review optimal dietary interventions for GI disorders. Vascular Diseases of the GI Tract\u003c\/li\u003e\n\u003cli\u003ePaul Feuerstadt, MD, FACG\u003c\/li\u003e\n\u003cli\u003eDiscuss the common presentations of the vascular diseases of the GI tract, including colonic ischemia, and acute and chronic mesenteric ischemia. PPI Risks – What Should We Be Telling Our Patients in 2021?\u003c\/li\u003e\n\u003cli\u003ePaul Moayyedi, MB ChB, PhD, MPH, FACG\u003c\/li\u003e\n\u003cli\u003eReview the risks, benefits, and discussions to be held with patients to maximize efficacy and minimize risk of PPI medications. Hereditary Colorectal Cancer Syndromes: Strategies for Monitoring and Prevention\u003c\/li\u003e\n\u003cli\u003eCarol A. Burke, MD, FACG\u003c\/li\u003e\n\u003cli\u003eReview various hereditary colon cancer syndromes, including a practical algorithm for screening and surveillance. Diverticular Disease in 2021: Where Are We Now?\u003c\/li\u003e\n\u003cli\u003eLisa L. Strate MD, MPH, FACG\u003c\/li\u003e\n\u003cli\u003eReview epidemiology and burden of diverticular disease, optimize management of diverticular complications, and describe treatment strategies for SUDD (symptomatic uncomplicated diverticular disease) and SCAD (segmental colitis associated with diverticula). Viral Hepatitis From A-Z\u003c\/li\u003e\n\u003cli\u003ePaul Y. Kwo, MD, FACG\u003c\/li\u003e\n\u003cli\u003eReview the natural history, diagnosis, and evidence-based management for common and rare etiologies of viral hepatitis. Fecal Incontinence – Strategies for 2021\u003c\/li\u003e\n\u003cli\u003eSatish S. C. Rao, MD, PhD, FACG\u003c\/li\u003e\n\u003cli\u003eReview the epidemiology and diagnostic approach for fecal incontinence, describe state-of-the-art management in 2021, and future novel\/emerging therapies. Gastric Intestinal Metaplasia and Gastric Polyps – Optimal Resection and Surveillance Strategies\u003c\/li\u003e\n\u003cli\u003eDouglas R. Morgan, MD, MPH, FACG\u003c\/li\u003e\n\u003cli\u003eProvide an evidence-based workflow to determine how to monitor gastric intestinal metaplasia, fundic polyps, and hyperplastic polyps. SIBO – Optimal Strategies for Testing and Treatment\u003c\/li\u003e\n\u003cli\u003eWilliam D. Chey, MD, FACG\u003c\/li\u003e\n\u003cli\u003eReview the best testing and treatment strategies for SIBO, as well as differentiating methane versus hydrogen-predominant pathology. Autoimmune Hepatitis and Cholangiopathies: Decoding Overlap Syndromes\u003c\/li\u003e\n\u003cli\u003eMarlyn J. Mayo, MD, FACG\u003c\/li\u003e\n\u003cli\u003eDiscuss the epidemiology, diagnosis, and management of autoimmune hepatitis, cholangiopathies, and overlap syndromes, including indications for when to start and stop therapy. ID for the GI – GI Presentations of Unusual Infections (Parasitic, Rickettsial, and Atypical Bacterial Infections)\u003c\/li\u003e\n\u003cli\u003eMark S. Riddle, MD, DrPH\u003c\/li\u003e\n\u003cli\u003eReview the unusual presentations and manifestations of some rarer causes of gastrointestinal infection. Digital Health in Gastroenterology: A New Frontier\u003c\/li\u003e\n\u003cli\u003eBrennan M. Spiegel, MD, MSHS, FACG\u003c\/li\u003e\n\u003cli\u003eDiscuss the role of digital health in gastroenterology, and the implications for research and clinical practice. Endoscopic Ultrasound 101– The Basics and the Emerging Role of LAMS for Complex Anatomy and Pancreatobiliary Disorders\u003c\/li\u003e\n\u003cli\u003eSeth A. Gross, MD, FACG\u003c\/li\u003e\n\u003cli\u003eReview the modality of EUS and the use of luminal apposing metal stents for GI pathology, including LAMS-assisted endoscopic drainage, and when to refer to an interventional gastroenterologist versus referral to a surgeon. Interpretation of Esophageal pH Impedance, Manometry: A Case-Based Approach\u003c\/li\u003e\n\u003cli\u003eFelice Schnoll-Sussman, MD, FACG\u003c\/li\u003e\n\u003cli\u003eApply a practical approach to interpretation of esophageal pH-impedance and manometry studies. Cannabis for Gastrointestinal Disorders: Everything You Wanted to Know, But Were Afraid to Ask\u003c\/li\u003e\n\u003cli\u003eLinda Anh B. Nguyen, MD\u003c\/li\u003e\n\u003cli\u003eProvide an overview of the endocannabinoid system and identify the role of cannabinoids in the treatment of functional and inflammatory bowel disease. Geriatrics and Gastrointestinal Disorders: Is Age Only a Number?\u003c\/li\u003e\n\u003cli\u003eBharati Kochar, MD, MSCR\u003c\/li\u003e\n\u003cli\u003eExplain the impact of aging on various GI disorders, discuss the concepts of frailty and polypharmacy, and provide an algorithmic approach to optimally manage geriatric patients with GI disorders. Extraintestinal Manifestations in IBD: Beyond the Bowel\u003c\/li\u003e\n\u003cli\u003eAnne G. Tuskey, MD, FACG\u003c\/li\u003e\n\u003cli\u003eReview epidemiology and management of EIMs, including paradoxical manifestations and hidradenitis suppurativa. Benign Liver Masses – How to Image, When to Resect: Maximal Yield and Minimal Patient Inconvenience\u003c\/li\u003e\n\u003cli\u003eJoseph Ahn, MD, MS, MBA, FACG\u003c\/li\u003e\n\u003cli\u003eReview the differential of benign liver masses, appropriate imaging protocols for diagnosis, and describe indications (if ever) for biopsy and\/or resection. Challenging IBD Cases – A Discussion With the Experts from IBD Circle\u003c\/li\u003e\n\u003cli\u003eSamir A. Shah, MD, FACG, and Jean-Paul Achkar, MD, FACG\u003c\/li\u003e\n\u003cli\u003eApply evidence-based clinical decision-making approaches to various challenging IBD cases encountered by the practicing gastroenterologist.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954402955362,"sku":"MED-AMB02789","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/24-Postgraduate-Course-Bonus-Sessions-2021.jpg?v=1779375543","url":"https:\/\/meducourse.com\/products\/24-postgraduate-course-bonus-sessions-2021","provider":"Meducourse","version":"1.0","type":"link"}